Renal and Systemic Effects of Calorie Restriction in Patients With Type 2 Diabetes With Abdominal Obesity: A Randomized Controlled Trial
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
In individuals with type 2 diabetes with abdominal obesity, hyperfiltration is a risk factor for accelerated glomerular filtration rate (GFR) decline and nephropathy. In this academic, single-center, parallel-group, prospective, randomized, open-label, blinded end point trial, consenting patients with type 2 diabetes aged >18 years, with waist circumference >94 (males) or >80 (females) cm, serum creatinine <1.2 mg/dL, and normoalbuminuria were randomized (1:1) with permuted blocks to 6 months of a 25% calorie restricted (CR) or standard diet (SD). Primary outcome was measured GFR (iohexol plasma clearance). Analyses were by modified intention to treat. At 6 months, GFR significantly decreased in 34 patients on CR and did not change appreciably in 36 on SD. Changes were significantly different between the groups. GFR and body weight reduction were correlated. GFR reduction was larger in hyperfiltering (GFR >120 mL/min) than nonhyperfiltering patients and was associated with BMI, waist circumference, blood pressure, heart rate, HbA1c, blood glucose, LDL-to-HDL cholesterol ratio, C-reactive protein, angiotensin II, and albuminuria reduction and with increased glucose disposal rate (measured by hyperinsulinemic-euglycemic clamps). Protein and sodium intake and concomitant treatments were similar between the groups. CR was tolerated well. In patients with type 2 diabetes with abdominal obesity, CR ameliorates glomerular hyperfiltration, insulin sensitivity, and other cardiovascular risk factors, effects that might translate into long-term nephro- and cardioprotection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Longitudinal Studies on the Rate of Decline in Renal Function with Age
Lindeman, R. D., Tobin, J., & Shock, N. W. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb07117.x · Cited by 1,578
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
BLAIR, S. N., HASKELL, W. L., HO, P., PAFFENBARGER, R. S., VRANIZAN, K. M., FARQUHAR, J. W., & WOOD, P. D. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114163 · Cited by 1,104 · cited 1×
“Dietary prescriptions were based on energy intake at baseline, estimated by the subjects’ resting metabolic rate (RMR) using the Mifflin predictive equation (19), and results from the Physical Activity Recall (PAR) and Total Daily Energy Expenditure (TDEE) questionnaire (20).”
MethodObesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Glomerular hemodynamics in severe obesity
Chagnac, A., Weinstein, T., Korzets, A., Ramadan, E., Hirsch, J., & Gafter, U. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.5.f817 · Cited by 614
Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials
Hansson, L., Hedner, T., & Dahlöf, B. (1992) · Blood Pressure · doi:10.3109/08037059209077502 · Cited by 577
Functional and Structural Changes in the Kidney in the Early Stages of Obesity
HENEGAR, J. R., BIGLER, S. A., HENEGAR, L. K., TYAGI, S. C., & HALL, J. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261211 · Cited by 549
The Effects of Weight Loss on Renal Function in Patients with Severe Obesity
Chagnac, A., Weinstein, T., Herman, M., Hirsh, J., Gafter, U., & Ori, Y. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000068462.38661.89 · Cited by 541
Nelson, R. G., Bennett, P. H., Beck, G. J., Tan, M., Knowler, W. C., Mitch, W. E., Hirschman, G. H., & Myers, B. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611283352203 · Cited by 477
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney
Ruiz-Ortega, M., Ruperez, M., Lorenzo, O., Esteban, V., Blanco, J., Mezzano, S., & Egido, J. (2002) · Kidney International · doi:10.1046/j.1523-1755.62.s82.4.x · Cited by 425
Overweight, Obesity, and the Development of Stage 3 CKD: The Framingham Heart Study
Foster, M. C., Hwang, S.-J., Larson, M. G., Lichtman, J. H., Parikh, N. I., Vasan, R. S., Levy, D., & Fox, C. S. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.03.003 · Cited by 403
Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate.
Gaspari, F., Perico, N., Ruggenenti, P., Mosconi, L., Amuchastegui, C. S., Guerini, E., Daina, E., & Remuzzi, G. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v62257 · Cited by 375
Self-citationNonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Ahmed, A., Wong, R. J., & Harrison, S. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.029 · Cited by 327
Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
Ruggenenti, P., Porrini, E. L., Gaspari, F., Motterlini, N., Cannata, A., Carrara, F., Cella, C., Ferrari, S., Stucchi, N., Parvanova, A., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2189 · Cited by 321
Self-citationHolloszy, J. O., & Fontana, L. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.03.009 · Cited by 304
Self-citationMetabolically Healthy Obesity and Development of Chronic Kidney Disease: A Cohort Study
Chang, Y., Ryu, S., Choi, Y., Zhang, Y., Cho, J., Kwon, M.-J., Hyun, Y. Y., Lee, K.-B., Kim, H., Jung, H.-S., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1323 · Cited by 283
Validation of several established equations for resting metabolic rate in obese and nonobese people
Frankenfield, D. C., Rowe, W. A., Smith, J. S., & Cooney, R. N. (2003) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(03)00982-9 · Cited by 237
De Cosmo, S., Menzaghi, C., Prudente, S., & Trischitta, V. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs290 · Cited by 219
Effects of weight loss on renal function in obese CKD patients: a systematic review
Bolignano, D., & Zoccali, C. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft302 · Cited by 211
The clinical significance of hyperfiltration in diabetes
Jerums, G., Premaratne, E., Panagiotopoulos, S., & MacIsaac, R. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1794-9 · Cited by 198
Chagnac, A., Herman, M., Zingerman, B., Erman, A., Rozen-Zvi, B., Hirsh, J., & Gafter, U. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn379 · Cited by 195
Insulin Resistance and Microalbuminuria
Parvanova, A. I., Trevisan, R., Iliev, I. P., Dimitrov, B. D., Vedovato, M., Tiengo, A., Remuzzi, G., & Ruggenenti, P. (2006) · Diabetes · doi:10.2337/db05-1484 · Cited by 189
Self-citationRenal hyperfiltration related to diabetes mellitus and obesity in human disease
Sasson, A. N. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i1.1 · Cited by 158
Wuerzner, G., Pruijm, M. T., Maillard, M. P., Bovet, P., Renaud, C. J., Burnier, M., & Bochud, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.03.017 · Cited by 135
Impact of obesity on autonomic modulation, heart rate and blood pressure in obese young people
Rossi, R. C., Vanderlei, L. C. M., Toledo, A. C. C. G., Vanderlei, F. M., Bernardo, A. F. B., Yamada, K. M. H., da Silva, N. T., & de Abreu, L. C. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.07.424 · Cited by 133
Hillis, G. S., Woodward, M., Rodgers, A., Chow, C. K., Li, Q., Zoungas, S., Patel, A., Webster, R., Batty, G. D., Ninomiya, T., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2471-y · Cited by 117
C-Reactive Protein: Clinical and Epidemiological Perspectives
Salazar, J., Martínez, M. S., Chávez, M., Toledo, A., Añez, R., Torres, Y., Apruzzese, V., Silva, C., Rojas, J., & Bermúdez, V. (2014) · Cardiology Research and Practice · doi:10.1155/2014/605810 · Cited by 117
de Jonge, L., Moreira, E. A. M., Martin, C. K., Ravussin, E., & Pennington CALERIE Team (2010) · Obesity · doi:10.1038/oby.2009.408 · Cited by 115
Heart rate and cardiovascular protection
Caetano, J., & Alves, J. D. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.02.009 · Cited by 112
Kim, S., Soltani‐Bejnood, M., Quignard‐Boulangé, A., Massiéra, F., Teboul, M., Ailhaud, G. P., Kim, J. H., Moustaïd‐Moussa, N., & Voy, B. H. (2006) · BioMed Research International · doi:10.1155/jbb/2006/27012 · Cited by 101
Ruggenenti, P. L., Porrini, E., Motterlini, N., Perna, A., Parvanova, A. I., Iliev, I. P., Dodesini, A. R., Trevisan, R., Bossi, A. C., Sampietro, G., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030252 · Cited by 94
Self-citationSteckelings, U. M., Rompe, F., Kaschina, E., & Unger, T. (2009) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00780.x · Cited by 92
Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes
Fufaa, G. D., Weil, E. J., Lemley, K. V., Knowler, W. C., Brosius, F. C., Yee, B., Mauer, M. S., & Nelson, R. G. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05760515 · Cited by 89
Glomerular Hyperfiltration in the Prediction of Nephropathy in IDDM: A 10-Year Follow-Up Study
Yip, J. W., Jones, S. L., Wiseman, M. J., Hill, C. E., & Viberti, G. C. (1996) · Diabetes · doi:10.2337/diab.45.12.1729 · Cited by 85
Silveiro, S. P., Friedman, R., de Azevedo, M. J., Canani, L. H. S., & Gross, J. L. (1996) · Diabetes Care · doi:10.2337/diacare.19.2.171 · Cited by 76
Hillis, G. S., Hata, J., Woodward, M., Perkovic, V., Arima, H., Chow, C. K., Zoungas, S., Patel, A. A., Poulter, N. R., Mancia, G., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002832 · Cited by 75
Dessı̀-Fulgheri, P., Sarzani, R., Serenelli, M., Tamburrini, P., Spagnolo, D., Giantomassi, L., Espinosa, E., & Rappelli, A. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.658 · Cited by 71
Renal consequences of obesity.
Naumnik, B., & Myśliwiec, M. (2010) · PubMed · Cited by 47
Rudberg, S. L., Dahlquist, G. G., Aperia, A. C., & Persson, B. (1988) · Diabetologia · doi:10.1007/bf00265370 · Cited by 31
Protein intake and blood glucose as modulators of GFR in hyperfiltering diabetic patients
Jones, S. L., Kontessis, P. S., Wiseman, M. J., Dodds, R. A., Bognetti, E., Pinto, J. R., & Viberti, G. C. (1992) · Kidney International · doi:10.1038/ki.1992.234 · Cited by 25
Cited by
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 274
Sharifi-Rad, J., Rodrigues, C. F., Sharopov, F., Docea, A. O., Can Karaca, A., Sharifi-Rad, M., Kahveci Karıncaoglu, D., Gülseren, G., Şenol, E., Demircan, E., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17072326 · Cited by 285
Cortinovis, M., Perico, N., Ruggenenti, P., Remuzzi, A., & Remuzzi, G. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00559-y · Cited by 214
Self-citationEffect of Diet on Insulin Resistance in Polycystic Ovary Syndrome
Shang, Y., Zhou, H., Hu, M., & Feng, H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa425 · Cited by 171
Donia, T., & Khamis, A. A. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14109-9 · Cited by 133
Metadata
- Authors
- Ruggenenti, P., Abbate, M., Ruggiero, B., Rota, S., Trillini, M., Aparicio, C., Parvanova, A., Petrov Iliev, I., Pisanu, G., Perna, A., Russo, A., Diadei, O., Martinetti, D., Cannata, A., Carrara, F., Ferrari, S., Stucchi, N., Remuzzi, G., Fontana, L., & on behalf of the C.RE.S.O. Study Group
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Ospedale Papa Giovanni XXIII (IT)
- IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Centro di Ricerche Cliniche per le Malattie Rare “Aldo e Cele Daccò,” Bergamo, Italy
- University of Milan (IT)
- Washington University in St. Louis (US)
- Corresponding author
- Remuzzi, Giuseppe
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-09-15
- Volume
- 66
- Issue
- 1
- Pages
- 75-86
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2460846739
- Semantic Scholar
- 3954ce45ccbe6bf8dabb8c795083e24f11f846be
- Cited by
- 95
- References
- 40
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 14 · 2023: 11 · 2022: 15 · 2021: 15 · 2020: 12 · 2019: 6 · 2018: 4 · 2017: 2 · 2016: 2
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
- Funders
- Italian Ministry of Health
- Bakewell Foundation
- Longer Life Foundation
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- caloric restriction, type 2 diabetes, abdominal obesity, glomerular hyperfiltration, glomerular filtration rate, renal function, insulin sensitivity, albuminuria, weight loss, cardiovascular risk factors, renal protection, cardioprotection
- MeSH terms
- Aged, Angiotensin II, Body Weight, C-Reactive Protein, Diabetes Mellitus, Type 2, Female, Glomerular Filtration Rate, Humans, Kidney, Kidney Function Tests, Male, Middle Aged, Risk Factors, Caloric Restriction, Obesity, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.